I made a mistake in the title of post
It should read
Dr Serge Mignani - Director - Sanofi Aventis - Dendrimers - Starpharma
and not
Dr Serge Mignani - Director - Sanofi Aventis - Director- Starpharma
Other than this the post is exactly the same as my previous one
Below is Dr Serge Mignani (Director) of Sinofi Aventis France, in a seminar giving a lecture on dendrimers for drug delivery application dated 8th September 2016r
I won't bother to explain the reason of this post (as recently my posts have generally been ridiculed by non holders and a few sarcastic posters)
You can all put the dots together
I will give you a clue however
Sanofi Avantis markets the off patent side effect causing cancer drug docetaxel
Be a detective.
Do some research
Dr Serge Mignani - Director - Sanofi Aventis - Dendrimers - Starpharma
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.0¢ | 9.6¢ | $5.703K | 58.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.41pm 11/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |